DiscoverAACE PodcastsEpisode 68: Impulse Control Disorders in Patients with Hyperprolactinemia on Dopamine Agonist Therapy
Episode 68: Impulse Control Disorders in Patients with Hyperprolactinemia on Dopamine Agonist Therapy

Episode 68: Impulse Control Disorders in Patients with Hyperprolactinemia on Dopamine Agonist Therapy

Update: 2025-09-29
Share

Description

Join Elizabeth M. Bauer, MD, FACP, FACE, Dipl ABOM, as she interviews Nicholas A. Tritos, MD, DSc, Professor of Clinical Medicine at Harvard Medical School and faculty of the Neuroendocrine Unit/Neuroendocrine and Pituitary Tumor Clinical Center at Massachusetts General Hospital, about his Endocrine Practice article, Impulse Control Disorders in Patients with Hyperprolactinemia on Dopamine Agonist Therapy – How Concerned Should We Be? The conversation explores the prevalence and risk factors for impulse control disorders, underlying biological mechanisms, clinical screening strategies, and approaches to patient counseling and management. Read the full article in the July 2025 issue of Endocrine Practice here: https://doi.org/10.1016/j.eprac.2025.04.018

Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Episode 68: Impulse Control Disorders in Patients with Hyperprolactinemia on Dopamine Agonist Therapy

Episode 68: Impulse Control Disorders in Patients with Hyperprolactinemia on Dopamine Agonist Therapy

AACE